Parexel Named “Best Contract Research Organization” at 21st Annual Scrip Awards

Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, has been named “Best Contract Research Organization” in the Full-Service Provider category at the 21^st annual Scrip Awards. This honor recognizes Parexel’s continued excellence in partnering with biopharma companies to design, drive and execute all aspects of clinical trials as well as the company’s vital contributions to drug development, patient impact and global public health. 

"This recognition belongs to all of our 20,000+ exceptional global colleagues who dedicate themselves daily to making real and meaningful differences for patients,” said Peyton Howell, Chief Executive Officer. “Being named this year’s ‘Best CRO’ reflects our commitment to advancing patient-guided clinical development and building strong and effective collaborations with our customers and site partners – all with the goal of accelerating the delivery of life-changing treatments to patients.” 

Parexel was selected by an independent panel of distinguished judges as a result of its demonstrated excellence in delivering results that exceed sponsor expectations, innovations in patient engagement and recruitment, commitment to patient access and inclusion in clinical trials, and the ability to leverage AI to improve speed and quality of the clinical development process.

The Scrip Awards, organized by Citeline, bring together over 400 industry leaders to honor and celebrate the best innovations and achievements in the global biopharma landscape from the past year. Open to any research-based pharmaceutical and biotech company worldwide as well as service providers to the pharmaceutical industry, the Scrip Awards recognize winners across diverse categories encompassing a wide range of industry achievements, with entries reviewed by independent judges.